Lab
Lab Plus, LLC
Lab Plus, LLC was paid $2.16M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 17% of everything it billed.
33Billing provider infoLAB PLUS, LLC
MURFREESBORO, TN 37129
MURFREESBORO, TN 37129
33aNPI1538400098assigned 03/08/2013
33bProvider typeClinical Medical Laboratory
28Total paid$2.16M
24GClaims623,290
24DCodes billed160
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Tennessee
Rank by total paid#21 of 70
Median peer was paid$141K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 108,404 | $275K | |
| 2019 | 138,027 | $356K | |
| 2020 | 123,992 | $457K | |
| 2021 | 138,512 | $543K | |
| 2022 | 99,807 | $487K | |
| 2023 | 9,866 | $26K | |
| 2024incomplete | 4,682 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 17% | 7,045 | 6,363 | $362K |
| 80053 | Comprehensive metabolic panel | 5.5% | 57,832 | 48,502 | $119K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.4% | 36,106 | 30,330 | $116K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.4% | 19,882 | 16,472 | $116K |
| 80061 | Lipid panel | 4.8% | 42,360 | 35,305 | $104K |
| 80050 | General health panel | 4.0% | 8,163 | 6,901 | $87K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.1% | 41,851 | 34,845 | $67K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.0% | 6,494 | 5,535 | $64K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.0% | 6,467 | 5,512 | $64K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 35,712 | 29,059 | $62K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.7% | 3,920 | 3,658 | $58K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.5% | 3,512 | 2,903 | $54K |
148 more codes
| 85027 | 2.0% | 26,511 | $43K | |
| 82607 | 1.9% | 12,009 | $41K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.7% | 1,711 | $38K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 58,635 | $35K |
| 82728 | 1.5% | 11,379 | $33K | |
| 86703 | 1.4% | 8,485 | $31K | |
| 84439 | 1.3% | 14,166 | $29K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 14,370 | $26K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 854 | $25K |
| 83880 | <1% | 3,510 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 15,661 | $21K |
| 80074 | <1% | 2,799 | $20K | |
| 82746 | <1% | 6,164 | $20K | |
| 87480 | <1% | 3,088 | $19K | |
| 87510 | <1% | 2,953 | $18K | |
| 87660 | <1% | 2,925 | $18K | |
| 83970 | <1% | 1,899 | $17K | |
| 87522 | Neg quan hep c or qual rna | <1% | 1,644 | $17K |
| 83013 | <1% | 826 | $16K | |
| 86803 | <1% | 4,476 | $15K | |
| 86235 | <1% | 1,177 | $14K | |
| 83550 | <1% | 7,297 | $13K | |
| 84403 | <1% | 1,832 | $12K | |
| 87077 | <1% | 5,487 | $12K | |
| 84481 | <1% | 2,537 | $11K | |
| 86160 | <1% | 1,647 | $10K | |
| 87186 | <1% | 4,678 | $10K | |
| 84480 | <1% | 2,704 | $10K | |
| 80055 | <1% | 876 | $10K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,311 | $10K |
| 81001 | <1% | 12,219 | $10K | |
| 84153 | <1% | 3,303 | $10K | |
| 86038 | <1% | 2,997 | $9K | |
| 87340 | <1% | 3,272 | $7K | |
| 82248 | <1% | 3,756 | $7K | |
| 84270 | <1% | 1,211 | $7K | |
| 86762 | <1% | 1,428 | $7K | |
| 82247 | <1% | 3,619 | $7K | |
| 85610 | <1% | 6,583 | $7K | |
| 84702 | <1% | 1,693 | $6K | |
| 83001 | <1% | 1,236 | $6K | |
| 83735 | <1% | 4,186 | $6K | |
| 86376 | <1% | 1,371 | $6K | |
| 86592 | <1% | 5,110 | $6K | |
| 82043 | <1% | 7,721 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 678 | $6K |
| 83516 | <1% | 1,551 | $6K | |
| 82570 | <1% | 5,382 | $6K | |
| 85651 | <1% | 6,724 | $6K | |
| 86140 | <1% | 4,390 | $5K | |
| 84146 | <1% | 1,012 | $5K | |
| 84402 | <1% | 794 | $5K | |
| 83690 | <1% | 2,521 | $5K | |
| 80076 | <1% | 3,103 | $5K | |
| 83655 | <1% | 1,187 | $5K | |
| 88142 | <1% | 1,029 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 167 | $5K |
| 87070 | <1% | 2,180 | $5K | |
| 82951 | <1% | 1,015 | $4K | |
| 82550 | <1% | 2,713 | $4K | |
| 87902 | <1% | 99 | $4K | |
| 87081 | <1% | 1,929 | $4K | |
| 86431 | <1% | 2,973 | $4K | |
| 86200 | <1% | 1,165 | $4K | |
| 86850 | <1% | 1,425 | $4K | |
| 82784 | <1% | 1,010 | $4K | |
| 83002 | <1% | 709 | $4K | |
| 83021 | <1% | 558 | $3K | |
| 86787 | <1% | 739 | $3K | |
| 86225 | <1% | 895 | $3K | |
| 82670 | <1% | 420 | $3K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 85 | $3K |
| 84550 | <1% | 2,670 | $3K | |
| 82150 | <1% | 1,338 | $2K | |
| 86706 | <1% | 1,002 | $2K | |
| 86480 | <1% | 98 | $2K | |
| 86039 | <1% | 678 | $2K | |
| 81003 | <1% | 2,783 | $2K | |
| 82105 | <1% | 482 | $2K | |
| 86141 | <1% | 518 | $2K | |
| 80164 | <1% | 728 | $2K | |
| 87338 | <1% | 284 | $1K | |
| 83540 | <1% | 1,239 | $1K | |
| 84134 | <1% | 381 | $1K | |
| 86900 | <1% | 1,526 | $1K | |
| 86901 | <1% | 1,526 | $1K | |
| 86696 | <1% | 223 | $1K | |
| 86769 | <1% | 86 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 98 | $1K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 387 | $1K |
| 87205 | <1% | 877 | $945.55 | |
| 86735 | <1% | 401 | $911.34 | |
| 87486 | <1% | 85 | $767.10 | |
| 87581 | <1% | 85 | $767.09 | |
| 84144 | <1% | 137 | $757.22 | |
| 82977 | <1% | 449 | $687.61 | |
| 86800 | <1% | 153 | $666.87 | |
| 84156 | <1% | 844 | $658.19 | |
| 87516 | <1% | 59 | $641.29 | |
| 84681 | <1% | 137 | $614.45 | |
| 82533 | <1% | 172 | $560.58 | |
| 86708 | <1% | 205 | $559.05 | |
| 85730 | <1% | 346 | $501.43 | |
| 86665 | <1% | 55 | $465.18 | |
| 36416 | <1% | 1,163 | $451.75 | |
| 84445 | <1% | 40 | $433.53 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 48 | $420.10 |
| 82565 | <1% | 262 | $382.30 | |
| 86704 | <1% | 144 | $367.39 | |
| 81511 | <1% | 15 | $361.61 | |
| 80177 | <1% | 135 | $361.45 | |
| 84460 | <1% | 342 | $354.79 | |
| 84425 | <1% | 84 | $341.49 | |
| 81025 | <1% | 84 | $257.32 | |
| 85018 | <1% | 298 | $239.74 | |
| 87209 | <1% | 56 | $239.18 | |
| 86664 | <1% | 55 | $218.75 | |
| 86695 | <1% | 59 | $214.72 | |
| 82330 | <1% | 80 | $210.14 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 38 | $198.64 |
| 86663 | <1% | 56 | $192.39 | |
| 87046 | <1% | 54 | $191.36 | |
| 86255 | <1% | 66 | $188.68 | |
| 85379 | <1% | 60 | $161.46 | |
| 87177 | <1% | 72 | $157.91 | |
| 86709 | <1% | 52 | $136.97 | |
| 84450 | <1% | 156 | $135.05 | |
| 86334 | <1% | 45 | $134.70 | |
| 84207 | <1% | 13 | $129.17 | |
| 82952 | <1% | 88 | $120.78 | |
| 83520 | <1% | 64 | $103.26 | |
| 87045 | <1% | 54 | $95.62 | |
| 86381 | <1% | 14 | $76.15 | |
| 84703 | <1% | 31 | $72.50 | |
| 82652 | <1% | 14 | $67.14 | |
| 87075 | <1% | 44 | $66.70 | |
| 84165 | <1% | 44 | $65.74 | |
| 86765 | <1% | 15 | $65.60 | |
| 86256 | <1% | 36 | $61.32 | |
| 82103 | <1% | 16 | $57.96 | |
| 84100 | <1% | 71 | $53.19 | |
| 83525 | <1% | 27 | $52.96 | |
| 80069 | <1% | 43 | $45.19 | |
| 82465 | <1% | 31 | $40.52 | |
| 83883 | <1% | 13 | $26.46 | |
| 87324 | <1% | 16 | $25.47 | |
| 84436 | <1% | 12 | $14.31 | |
| 84520 | <1% | 15 | $4.81 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPRINGER, KAREN (CHIEF OPERATING OFFICER)
Parent organizationSAINT THOMAS HEALTH
| Provider | Location | Paid |
|---|---|---|
| Saint Thomas Health | Nashville, TN | $713K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.